argon has been researched along with Cardiovascular Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belloli, A; De Maglie, M; Di Giancamillo, M; Fries, M; Fumagalli, F; Latini, R; Locatelli, V; Masson, S; Novelli, D; Ristagno, G; Russo, I; Scanziani, E; Staszewsky, L; Tantillo, S; Vago, T; Zani, DD | 1 |
Pagel, PS | 1 |
Kersten, JR; Krolikowski, JG; Pagel, PS; Pratt, PF; Shim, YH; Venkatapuram, S; Warltier, DC; Weihrauch, D | 1 |
3 other study(ies) available for argon and Cardiovascular Stroke
Article | Year |
---|---|
Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest.
Topics: Animals; Argon; Brain Ischemia; Cardiopulmonary Resuscitation; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Arrest; Hemodynamics; Hippocampus; Male; Myocardial Infarction; Neuroprotective Agents; Sus scrofa; Treatment Outcome | 2014 |
Cardioprotection by noble gases.
Topics: Anesthesia, Inhalation; Animals; Argon; Dogs; Heart; Helium; HSP27 Heat-Shock Proteins; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Neon; Rabbits; Rats; Swine; Xenon | 2010 |
Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Topics: Androstadienes; Animals; Argon; Atractyloside; Cardiotonic Agents; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Heart Ventricles; Helium; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neon; Noble Gases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Kinases; Rabbits; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Wortmannin | 2007 |